# Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers

> **NCT02442739** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Cedars-Sinai Medical Center**

## Conditions studied

- Head and Neck Cancer
- Pancreatic Cancer
- Depression

## Interventions

- **DRUG:** Ketamine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02442739
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-08-15
- **Primary completion:** 2017-11-03
- **Final completion:** 2017-11-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI voluntary closure due to low accrual
- **Last updated:** 2018-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02442739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02442739, "Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers". Retrieved via MORVS 2026-09-29 from https://api.ai-analytics.org/clinical/NCT02442739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*